RTW Biotech Opportunities Ltd

RTW.L: LSE
88Total

Lowest reading is at 77 out of 100. All scores are out of 100.

About The Company

CEO

Baroness Nicola Blackwood

Market Cap

757.89 Million USD

Sector

Financial Services

Website

https://www.rtwfunds.com/rtw-biotech-opportunities-ltd

Last Update

28/09/2026, 03:21:23

Description

RTW Biotech Opportunities Ltd is a venture capital fund.

Read More

Strongest readings

  • ✔Cashflow and earnings growth is strong (growth score 100 out of 100)
  • ✔Price-to-earnings of 3.7 is below the market average of 19.6

Weakest readings

  • ✘Share count has been rising at 18.82% per year

Key Figures

StatusMetricValueReadingMarket avg
✔
Price / earnings (TTM)
3.75x
19.60x
✘
Margin of safety (DCF)
14.16%
17.95%
✔
Revenue growth (5y average)
246.34%
10.97%
✘
Dividend yield (TTM)
0.00%
1.85%
✘
Share count, per year
18.82%
0.00%
Return on capital employedN/A10.00%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

Valuation

87 / 100

Priced at or below the market on most measures.

StatusMetricValueReadingMarket avg
✔
Price / earnings
3.75x
19.60x
✔Free cashflow yield13.89%
4.70%
✔Price / earnings growth0.01x
1.50x
Price / book0.88x
—
✘
Margin of safety
14.16%
17.95%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✔Estimated intrinsic value of 2.69 USD is above the current price of 2.36 USD

Desired Margin Of Safety

0%

▼

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Estimated Fair Value: 2.8 USD ✔

Current Price: 2.4 USD

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.

Growth

100 / 100

Growing faster than the market on most measures.

StatusMetricValueReadingMarket avg
✔
Revenue growth
246.34%
10.97%
✔Earnings growth201.64%
14.48%
✔Cashflow growth223.95%
12.35%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    Health

    not enough data

    Not enough of the underlying data is reported to score this section.

    Measured on Leverage and capital, Funding and liquidity, Earnings quality.

    StatusMetricValueReadingThreshold
    Debt / equityN/A0.80x
    Debt / total capitalN/A1.00x
    Equity / assets80.93%
    —
    Debt / free cashflowN/A0.15x
    Interest coverageN/A2.50x

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

      Management

      77 / 100

      Returns on capital are at or above the market.

      StatusMetricValueReadingMarket avg
      ✔Return on equity28.34%
      15.00%
      Return on capital employedN/A10.00%
      Return on assets22.94%
      —
      Free cashflow return on capitalN/A—
      Return on capital, 5y changeN/A0.00%
      ✘
      Share count, per year
      18.82%
      0.00%
      ✔Share count, recent-17.49%
      0.00%
      Realized buyback returnN/A0.00%
      ✔Goodwill erosion / equity0.00%
      2.00%
      Price volatility, 5 year28.81%
      —

      The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

      • ✘New shares were issued while the value score was 87 out of 100
      • ✘Return on equity of 28.34% is driven by debt rather than operations, because return on capital employed is only N/A

      Analysts

      not enough data
      StatusMetricValueReadingNeutral
      Analyst opinion scoreN/A50

      The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

      Financial History

      Annual figures across the full reporting history we hold.

      Market Peers

      RTW.L

      SEC Filings

      Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

      See 35+ Years Annual Reports

      Other Information

      Company Name

      RTW Biotech Opportunities Ltd

      Currency

      USD

      Beta

      0.77

      Vol Avg

      318278

      Ceo

      Baroness Nicola Blackwood

      Cik

      Cusip

      Exchange

      LSE

      Full Time Employees

      Industry

      Asset Management

      Sector

      Financial Services

      Ipo Date

      Address

      40 10th Avenue

      City

      New York

      State

      NY

      Country

      United States

      Zip

      10014

      Phone

      646 597 6980

      Analysis Last Updated

      28/09/2026, 03:21:23

      Financial data compiled from SEC EDGAR filings and Yahoo Finance.

      Noticed an error with something on our site?

      Data, not advice. Do your own diligence.

      We Use Cookies